Evidence map›Paper›PMID 41039428›Full record

ArticleJournal of translational medicine2025

FGF21 maintains redox homeostasis and promotes neuronal survival after traumatic brain injury by targeting SLC25A39-mediated mitochondrial GSH transport.

Lekai Wang, Weiwei Li, Xun Wu, Qing Ouyang, Bing Sun, Jianing Luo, Heng Guo, Tao Yang, Yuan Ma

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lekai Wang *Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Weiwei Li *Department of Neurology, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Xun Wu *Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi, China.
Qing OuyangDepartment of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Bing SunDepartment of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Jianing LuoDepartment of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Heng GuoDepartment of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Tao YangDepartment of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China.
Yuan MaDepartment of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, 610083, China. tianfu_47@163.com.ORCID 0000-0003-4311-7105

Funding

Special Project for Scientific Research of Traditional Chinese Medicine in Sichuan Province 2023MS293Support Project of the General Hospital of the Western Theater Command 2021-XZYG-A13
6 · The paper itself

Abstract

backgroundTraumatic brain injury (TBI) represents a critical form of acute brain injury, characterized by considerable mortality and morbidity. Recently, fibroblast growth factor 21 (FGF21), a multifaceted hormone predominantly synthesized in liver, has emerged as a promising neuroprotective agent. In the study, we aim to investigate whether FGF21 exerts protective effects against TBI and to further elucidate its underlying molecular mechanisms.

methodsTo elucidate the role of FGF21 in regulating SLC25A39-dependent mitochondrial GSH transport and providing protection against TBI-induced neurological deficits, a series of cellular and molecular techniques, including western blot analysis, real-time polymerase chain reaction, immunohistochemistry, transmission electron microscope, and behavioral assays, were employed.

resultsFGF21 knockout exacerbates neural apoptosis and brain edema, increases lesion volume, and worsens neurological deficits following TBI. Remarkably, these pathological alterations were substantially mitigated with subsequent administration of recombinant FGF21. Importantly, FGF21 was found to prevent mitochondrial damage and sustain redox homeostasis post-TBI. Mechanistically, we observed that FGF21 enhances the mitochondrial uptake of glutathione (GSH), an essential redox metabolite, by targeting SLC25A39, a recently identified mitochondrial GSH transporter. FGF21 does not influence the transcriptional production of SLC25A39 but enhances its protein expression by inhibiting degradation via the mitochondrial protease AFG3L2. Furthermore, in neuron-specific Slc25a39 knockout mice, FGF21 was unable to exert its neuroprotective effects.

conclusionOur findings provide preliminary evidence that FGF21 confers protective effects against mitochondrial oxidative stress-related damage following TBI. Additionally, we elucidated a novel role for SLC25A39-dependent mitochondrial GSH transport in both the pathological processes subsequent to TBI and the physiological functions of FGF21.

Indexed as

Brain Injuries, TraumaticFibroblast Growth FactorsGlutathioneHomeostasisMitochondriaNeuronsAnimalsApoptosisBiological TransportBrain EdemaCell SurvivalMaleMiceMice, Inbred C57BLMice, KnockoutOxidation-Reductionfibroblast growth factor 21Fibroblast Growth FactorsGlutathioneFibroblast growth factor 21GlutathioneMitochondriaOxidative stressSLC25A39Traumatic brain injury

Identifiers

PMID41039428
PMCPMC12492758

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.